Skip to main navigation
Skip to search
Skip to main content
52nd Annual Meeting of the American Society of Hematology
Acute Lymphoblastic Leukamia (ALL) Research Group
Hiwase DK, Eadie LN, Saunders VA, Hughes TP, White DL.
Proton pump inhibitors augment nilotinib and dasatinib mediated Bcr-Abl kinase inhibition.
4 Dec 2010
7 Dec 2010